Prostaglandins (PGs) play a key role in the development on the immune response, through the regulation of both pro-and anti-inflammatory processes. PGD 2 can be either proor anti-inflammatory depending on the inflammatory milieu. Prostaglandin D synthethase (PGDS) is the enzyme responsible for the conversion of PGH 2 to PGD 2 . In mammals, two types of PGDS synthase have been described, the hematopoietic (H-PGDS) and the lipocalin (L-PGDS). In the present study we describe the existence of two orthologues of the mammalian L-PGDS (PGDS1 and PGDS2) in the gilthead seabream and characterize their gene expression profiles and biological activity. The results showed a dramatic induction of the gene coding for PGDS1 in acidophilic granulocytes (AGs), which are functionally equivalent to mammalian neutrophils, after a prolonged in vitro activation with different pathogen associated molecular patterns (PAMPs). In contrast PGDS2 was not expressed in these cells. The functional relevance of the induction of PGDS1 in AGs was confirmed by the ability of these cells to release PGD 2 upon PAMP stimulation. To gain further insights into the role of PGD 2 in the resolution of inflammation in fish, we examine the ability of PGD 2 or its cyclopentenona derivates (cyPGs) to modulate the main functional activities of AGs. It was found that both PGD 2 and cyPGs inhibited the production of reactive oxygen species and downregulated the transcript levels of the gene encoding interleukin-1 . Altogether, these results demonstrate that the use of PGD 2 and its metabolites in the resolution of inflammation was established before the divergence of fish from tetrapods more than 450 million years ago and support a critical role for granulocytes in the resolution of inflammation in vertebrates.
Introduction
Eicosanoids, including prostaglandins (PGs), leukotrienes (LTs) and lipoxins (LXs) are small fatty acid molecules derived from polyunsaturated fatty acids released from the cell membrane phospholipids, mainly araquidonic acid. Prostaglandins play a significant role in the progress of the immune response at multiple levels, often in concert with microbial ligands, cytokines, chemokines, and various other factors (Hirata and Narumiya, 2012) .
The first enzyme involved in PG biosynthesis is the cyclooxygenase (COX) which converts araquidonic acid to PGH 2 . There are several forms of COX: the COX-1 is constitutively expressed in nearly all cell types, while COX-2 is mainly inducible in inflammatory conditions and only expressed by a more limited range of cell types (Simmons et al., 2004) . PGH 2 is subjected to further conversion to give rise to the PG generation including PGE 2 and PGD 2 . (Joo and Sadikot, 2012) . PGD 2 is converted to cyPGs, i.e. 15-deoxy- 12,14 PGJ 2 and  12 PGJ 2 , by albumin-independent and dependent reactions, respectively (Shibata et al., 2002) .
PGD 2 synthase is the responsible for the production of PGD 2 (the major prostaglandin in the central nervous system and in immune cells) from PGH 2 . In the most evolutionary organisms, two distinct types of PGD 2 synthases have been identified: the hematopoietic form (H-PGDS) and the lipophilic ligand-carrier protein (lipocalin)-type enzyme (L-PGDS). These two enzymes share no homology in DNA and polypeptide sequences (Kanaoka et al., 1997) and show different tissue expression profiles, being L-PGDS mainly expressed in the CNS and related organs (Urade and Hayaishi, 2000) and H-PGDS in hematopoietic cells, including macrophages . Previous studies have reported an important role for H-PGDS in the control of the onset and resolution of acute inflammation (Rajakariar et al., 2007) . However, while H-PGDS is constitutively expressed in macrophages, the L-PGDS is not detected in macrophages in normal conditions but expressed in a pathological environment (Cipollone et al., 2004) . The production of PGD 2 by neutrophils has been controversial. Pouliot and coworkers reported that the main PGH 2 -derived metabolites produce in vitro by human neutrophil following activation with several inflammatory stimuli were TXB 2 and PGE 2 , whereas they did not observed a detectable level of PGD 2 (Pouliot et al., 1998) . However, two more recent studies have shown the production of PGD 2 by human neutrophils during spontaneous apoposis (Brown et al., 2003) and by mouse neutrophils during acute lung injury (Murata et al., 2013) . Strikingly, H-PGDS was responsible for the production of PGD 2 by mouse neutrophils (Murata et al., 2013) .
Taking into account that fish express several isoforms of L-PGDS, but none for H-PGDS, the aim of this study was to determine the role of PGDSs and their products, PGD 2 and cyPGDs, in the resolution of inflammation in the teleost fish gilthead seabream (Sparus aurata L.) and, in particular the contribution of acidophilic granulocytes (AGs), which are functionally equivalent to mammalian neutrophils (Cabas et al., 2013; Chaves-Pozo et al., 2005; Chaves-Pozo et al., 2004; Sepulcre et al., 2007; Sepulcre et al., 2011; Sepulcre et al., 2002) , to the production of PGD 2 .
Materials and Methods

Animals
Healthy specimens (150 g mean weight) of the hermaphroditic protandrous marine fish gilthead seabream (Sparus aurata, Actinoperygii, Sparidae) were bred and kept at the Oceanographic Centre of Murcia (Spain) in a 14 m 3 running seawater tank (dissolved oxygen 6 ppm, flow rate 20% tank volume/hour) with natural temperature and photoperiod, and fed twice a day with a commercial pellet diet (Skretting, Burgos, Spain). Fish were fasted for 24 hours before sampling. The experiments performed comply with the Guidelines of the European Union Council (86/609/EU) and the Bioethical Committee of the University of Murcia (Spain) for the use of laboratory animals.
Isolation of phagocytes
AGs were obtained by MACS as described earlier (Roca et al., 2006) . Briefly, head kidney cell suspensions were incubated with a 1:10 dilution of a mAb specific to gilthead seabream AGs (G7) (Sepulcre et al., 2002) , washed twice with PBS containing 2 mM EDTA (Sigma-Aldrich) and 5% FCS (Invitrogen) and then incubated with 100-200 l per 10 8 cells micro-magnetic-bead-conjugated anti-mouse IgG antibody (Miltenyi Biotec). After washing, G7 + (AGs) cell fractions were collected by MACS following the manufacturer's instructions and their purity analyzed by flow cytometry (Roca et al., 2006) .
Cell culture and treatments
Isolated AGs were stimulated at 23°C with 50 g/ml phenol-extracted genomic DNA ). The primers used are shown in Table   1 . In all cases, each PCR was performed with triplicate samples and repeated at least twice.
Measurement of PGD 2 by EIA
Evaluation of PGD 2 was synthesis were performed by analyzing supernatants from
AGs stimulated or not with VaDNA for one to 3 days using a commercial enzyme immunoassay (EIA) kit (Cayman Chemical).
Cell viability
Aliquots of cell suspensions were diluted in 200 l PBS containing 40 g/ml propidium iodide (PI). The number of red fluorescent cells (dead cells) from triplicate samples was analyzed by using flow cytometry.
Respiratory burst assays
Respiratory burst activity was measured as the luminol-dependent chemiluminescence produced by AGs after different times of stimulation (Mulero et al., 2001 ). This was brought by adding 100 M luminol and 1 g/ml PMA (both from Sigma-Aldrich), while the chemiluminescence was recorded every 117 seconds for 1 h in a FLUOstart luminometer (BGM, LabTechnologies). The values reported are the average of quadruple readings, expressed as the slope of the reaction curve from 117 to 1170 seconds, from which the apparatus background was subtracted.
Statistical analysis
Data were analyzed by ANOVA and a Tukey's multiple range test to determine differences between groups.
RESULTS
Identification of genes encoding PGDS in gilthead seabream
Searches within publicly available EST database of the European Nucleotide Archive (ENA) allowed us to identify two genes encoding for gilthead seabream PGDS1 and PGDS2
(ENA accession numbers AM971774 and AM959591, respectively) ( Fig. S1 ). An interesting difference between them was the presence of two ATTTA motifs in the 3' untranslated region (UTR) of the PGDS1. These motifs have been shown to be responsible for the unstability of mammalian (Han et al., 1990) and fish (Roca et al., 2007) non-mammalian (zebrafish, xenopus and chicken) and mammalian L-PGDS formed an "L-PGDS sub-family" in the lipocalin gene family (Fujimori et al., 2006) . One of the features of this family is the presence of conserved folding patterns and three structurally conserved regions (SCRs) (Flower, 1993) . Strikingly, however, zebrafish, rainbow trout and seabream L-PGDS all lacked in their primary structure the essential cysteine residue required for PGDS activity found in mammalian L-PGDS (Bayne et al., 2001; Fujimori et al., 2006; Urade et al., 1995) .
PGDS1 gene expression is induced upon AG activation
As the production of PGD 2 by mammalian neutrophils is controversial (Brown et al., 2003; Joo et al., 2007; Pouliot et al., 1998) , we analyzed the expression of PGDS1 and PGDS2 by RT-qPCR in seabream AGs, which are functionally equivalent to mammalian neutrophils (Cabas et al., 2013; Chaves-Pozo et al., 2005; Chaves-Pozo et al., 2004; Sepulcre et al., 2007; Sepulcre et al., 2011; Sepulcre et al., 2002) , following stimulation in vitro with different PAMPs. The results showed that VaDNA or flagellin stimulation resulted in a gradual increase of the mRNA levels of PGDS1 along the time of stimulation (Fig. 2a) .
Notably, PGDS2 was not expressed in control or stimulated AGs (data not shown). It is important to note that the expression of the genes encoding prostaglandin-endoperoxide synthase 2 (PTGS2 or COX2), the limiting enzyme in PGs production (Fig. 2b) , and interleukin-1 (IL-1) (Fig. 2c ) also showed a dramatic up-regulation but with different kinetics; peaking at the shortest time analyzed (1 day post-stimulation).
AGs produce PGD 2 following stimulation with PAMPs
The expression data obtained in AGs, together with the fact that previous reports have
shown that non-mammalian L-PGDSs have no, or very weak, PGDS activity (Fujimori et al., 2006) prompted us to analyze the production of PGD 2 by these cells. The results showed that AGs were able to produce PGD 2 in vitro and this production was significantly increased in response to stimulation with VaDNA (Fig.3) .
PGD 2 and its derivates inhibit AG functions
We next sought to determine the activity of PGD 2 in the main AG functions, i.e. the production of reactive oxygen species (ROS) and cytokines. We used 16,16-dimethyl-PGD 2 , a metabolically stable synthetic analogue of PGD 2 that signals through DP1 receptor (Gervais et al., 2001) , and the chemically stable ligand of 13,14-dihydro-15-keto-PGD 2 of the PGD2 metabolite 11-deoxy-11-methylene-15-keto-PGD 2 , which signals via the chemokine-related CRTH2 receptor (Hirai et al., 2001) . It was found that physiological concentrations of both compounds inhibited in a dose-dependent manner the induction of ROS upon VaDNA stimulation (Figs. 4a and 4b ). However, cell viability was unaffected (data not shown). It is important to note that the effects of 11-deoxy-11-methylene-15-keto-PGD 2 on ROS production was weaker than that of 16,16-dimethyl-PGD 2 . Similarly, only 16,16-dimethyl-PGD 2 was able to inhibit the induced mRNA levels of IL-1 in response to VaDNA (Fig. 4c) .
In the view of these results, we also analyzed the effect of the cyPGs, 15-deoxy- 12,14 PGJ 2 and  12 PGJ 2 , in AGs activities. Similar to PGD 2 , both cyPGs decreased ROS production in a dose-dependent manner (Figs. 5a and 5b ) and downregulated IL-1 expression by AGs (Fig.   5c ). It is important to note that cyPGs exert their effects at lower doses and were more potent in comparison with PGD 2 . Collectively, all these results indicate that PGD 2 and its derivates have a potent anti-inflammatory effect and suggest an important role of PGD 2 released by seabream AGs in the resolution of inflammation.
In vivo expression of seabream PGDSs and modulation upon bacterial infection
The analysis of the constitutive expression of seabream PGDSs genes showed that both genes were expressed in all tissue examined, including key immune organs, like headkidney, spleen, thymus and gills, with the exception of PGDS2 in the gut (Figs. 6a and 6b ). It is important to note that the highest mRNA levels of PGSD1 were found in liver, while those of PGDS2 were much higher in brain, gill and thymus.
To determine whether seabream PGDS might be involved in bacterial infection, healthy seabream juveniles were challenged with the fish pathogenic bacterium V.
anguillarum and then the expression of the gene encoding PTGS2, PGDS1 and PGDS2 were all analyzed. Notably, bacterial infection led to an increase in the mRNA levels of PTGS2 and PGSD1 in most of the tissues examined; being the blood the tissue where the increase was found to be the highest for the two genes (Figures 7a and 7b) . In contrast, the mRNA levels of PGDS2 did not significantly changed (peritoneal exudates and liver), or even decreased (head-kidney, thymus and gill), after the bacterial challenge, with the exception of the blood (Figure 7c ). All these data further support a role for PGDS1 in the resolution of the inflammatory response in the gilthead seabream.
Discussion
PGDS is the enzyme responsible of the conversion of PGH 2 to PGD 2 . Two types of PGDS synthase have been described, the hematopoietic (H-PGDS) and the lipocalin (L-PGDS). This in silico work has revealed the existence of two L-PGDS orthologues in gilthead seabream (PGDS1 and PGDS2). In addition, H-PGDS orthologues have not been identified so far in the fish genomes available, including ancient, i.e. the zebrafish (Cypriniformes), and most evolutionary advance, i.e. pufferfish (Tetraodontiformes), teleost fish. All these data point to L-PGDS as the responsible of PGD 2 synthesis in gilthead seabream. In addition, the results of the tissue distribution of both L-PGDS genes suggest different roles for these two molecules. In this context, in the view of that the highest levels of expression PGDS2 were found in the brain, together with its weak modulation after bacterial challenge, and taking into consideration that mammalian L-PGDS is mainly expressed in CNS and related organs (Taniike et al., 2002; Urade et al., 1993) , seabream PGDS2 might be considered functionally equivalent to mammalian L-PGDS.
A pro-inflammatory role of L-PGDS has been reported in models of allergic inflammation (Satoh et al., 2006) and other inflammation models (Hokari et al., 2011; Nagata et al., 2009; Ogawa et al., 2006; Uehara et al., 2009) . Other studies have shown using gain and loss of function strategies in mice an important role for L-PGDS in the innate immune response (Joo et al., 2007; Joo and Sadikot, 2012) . Here we have shown the induction of PGDS1 and PGDS2 expression in different tissues of seabream challenged with V.
anguillarum, but with different patterns, being in both cases the blood the tissue where the changes were more evident. The modulation of the expression of PGDS1 and PGDS2 by bacterial challenge was weaker in comparison with the changes observed in the mRNA levels of PTGS2, which is upstream in the prostanoid biosynthesis pathway. This means that other PGH 2 derivates could be involved in the clearance of the bacteria and resolution of the infection. Collectively, these results suggest that mainly seabream PGDSs would contribute to host defense against bacterial infection.
Previous studies have shown the contribution of L-PGDS in the production of PGD 2 by macrophages stimulated with LPS or bacterial infection (Joo et al., 2007) . However no reports exist about the contribution of L-PGDS in the production of PGD 2 by neutrophils.
Accumulating evidence suggests that seabream AGs could be considered the cell functional equivalent to mammalian neutrophils (Cabas et al., 2013; Chaves-Pozo et al., 2005; ChavesPozo et al., 2004; Sepulcre et al., 2007; Sepulcre et al., 2011; Sepulcre et al., 2002) . We Joo et al. (2007) showing that macrophages stimulated with LPS express PTGS2 before L-PGDS expression by differentially using key transcription factors (NF-B and AP-1, respectively), ensuring that a sufficient amount of PGH 2 is available for L-PGDS to produce PGD 2 (Joo et al., 2007) . In agreement with this, the expression of IL-1 , which is also modulated by NF-B, showed the same kinetics than PTGS2.
L-PGDS is a bifunctional protein, acting as a PGD 2 producing enzyme an also as an intercellular transporter of lipophilic molecules (Fujimori et al., 2006) . Previous studies have
shown that both zebrafish and chicken PGDSs lack enzymatic activity, while they are able to bind thyroxine and all-trans retinoic acid, like mammalian L-PGDSs and other lipocalin gene family proteins (Fujimori et al., 2006) . However, the role of this amino acid in the activity of fish L-PGDS homologues is not clear, since a zebrafish mutant L-PGDS with reconstituted cysteine (G59C) also lacks enzymatic activity (Fujimori et al., 2006) . Given the induction of seabream PGDS1 expression in AGs stimulated with PAMPs, we wondered to determine the production of PGD 2 by these cells and the contribution of PGDS1 in this process. Our results demonstrate that seabream AGs are able to produce PGD 2 and this production is increased upon stimulation with VaDNA with a similar kinetics than PGDS1 expression. These results suggest that PGDS1 may be responsible for the production of PGD 2 that, in turn, would be involved in the resolution of the inflammatory response in this species. Although further studies are needed for determine the role of seabream PGDS1 in this process, it is tempting to speculate that it could contribute to PGD 2 production by AGs. Nowadays, very few reports exist regarding the role of PGD 2 production by neutrophils and its role in the resolution of inflammation. Taken into account that gilthead seabream AGs are considered the functional equivalent to mammalian neutrophils, these results led us to hypothesize that the production of PGD 2 by neutrophils could be an essential component in the resolution of the inflammation in vertebrates.
The role of PGD 2 in immune response is complex because it can elicit proinflammatory and anti-inflammatory effects depending on the inflammatory milieu. In addition PGD 2 can exert its function by the interaction with two G protein-coupled receptors:
the D prostanoid recepor 1 (DP1) and the chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) (Gervais et al., 2001) . CRTH2 has been shown to be expressed in various mouse immune cells, including Th1 cells, Th2 cells, eosinophils, monocytes, and neutrophils (Kim and Luster, 2007; Takeshita et al., 2004) derivates.
In summary, in this study we provide proof that PGD 2 , likely produced by PGDS1, plays an important role in the resolution of the inflammation in gilthead seabream. In addition, we demonstrate that AGs, the cells functionally equivalent to mammalian neutrophils, synthesize PGD 2 that directly or via the production of its metabolites CyPGs regulates the resolution of the inflammatory response by controlling the balance of anti-vs.
pro-inflammatory mediators as well as by decreasing ROS production. Furthermore our results suggest the importance of L-PGDS in the production PGD 2 in lower vertebrates, which lacks H-PGDS. 
